相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells
Xiaoyan Ning et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Positive Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes
Da-zhi Xu et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Relation between outcomes and localisation of p-mTOR expression in gastric cancer
T. Murayama et al.
BRITISH JOURNAL OF CANCER (2009)
Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer
Guanzhen Yu et al.
CLINICAL CANCER RESEARCH (2009)
Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues
Donghui Zhou et al.
BMC CANCER (2008)
Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer
Sung Yong Oh et al.
BMC CANCER (2008)
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo
Daniel Cejka et al.
CANCER BIOLOGY & THERAPY (2008)
An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer
T. S. Liu et al.
EJSO (2008)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy
Leri S. Faried et al.
MOLECULAR CARCINOGENESIS (2008)
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
Mitsuru Sasako et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables
Woo Chul Noh et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients
Eva Lieto et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma
Beata Herberger et al.
CLINICAL CANCER RESEARCH (2007)
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery
Gennaro Galizia et al.
WORLD JOURNAL OF SURGERY (2007)
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model
Sven A. Lang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas - Association with poor outcome
Kim L. Wang et al.
CANCER (2007)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate
G Galizia et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation
I Beuvink et al.
CELL (2005)
Meta-analysis of intraperitoneal chemotherapy for gastric cancer
Da-Zhi Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
mTOR and P70S6 kinase expression in primary liver neoplasms
F Sahin et al.
CLINICAL CANCER RESEARCH (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer
AP Sutter et al.
ONKOLOGIE (2004)
Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer
I García et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
分享论文
